Fifth Third Bancorp’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.93M | Buy |
77,761
+12,160
| +19% | +$1.52M | 0.02% | 463 |
|
|
2025
Q4 | $8M | Sell |
65,601
-117
| -0.2% | -$13.4K | 0.03% | 267 |
|
|
2025
Q3 | $6.58M | Sell |
65,718
-4,226
| -6% | -$381K | 0.02% | 288 |
|
|
2025
Q2 | $5.8M | Sell |
69,944
-22,252
| -24% | -$1.78M | 0.02% | 295 |
|
|
2025
Q1 | $7.48M | Sell |
92,196
-22,119
| -19% | -$1.98M | 0.03% | 264 |
|
|
2024
Q4 | $10.3M | Sell |
114,315
-41
| -0% | -$3.97K | 0.04% | 238 |
|
|
2024
Q3 | $11.3M | Sell |
114,356
-3,947
| -3% | -$388K | 0.04% | 230 |
|
|
2024
Q2 | $11M | Buy |
118,303
+3,922
| +3% | +$352K | 0.04% | 229 |
|
|
2024
Q1 | $10.9M | Buy |
114,381
+8,287
| +8% | +$769K | 0.04% | 232 |
|
|
2023
Q4 | $9.47M | Sell |
106,094
-19,608
| -16% | -$1.46M | 0.04% | 236 |
|
|
2023
Q3 | $9.18M | Sell |
125,702
-19,354
| -13% | -$1.55M | 0.04% | 239 |
|
|
2023
Q2 | $12.1M | Sell |
145,056
-27,283
| -16% | -$2.28M | 0.05% | 222 |
|
|
2023
Q1 | $13.1M | Buy |
172,339
+21,925
| +15% | +$1.82M | 0.06% | 212 |
|
|
2022
Q4 | $12.5M | Sell |
150,414
-15,122
| -9% | -$1.22M | 0.06% | 222 |
|
|
2022
Q3 | $13.1M | Buy |
165,536
+2,031
| +1% | +$171K | 0.07% | 206 |
|
|
2022
Q2 | $12.1M | Sell |
163,505
-19,428
| -11% | -$1.46M | 0.06% | 221 |
|
|
2022
Q1 | $16.4M | Sell |
182,933
-5,799
| -3% | -$536K | 0.07% | 206 |
|
|
2021
Q4 | $21.1M | Sell |
188,732
-7,407
| -4% | -$893K | 0.08% | 186 |
|
|
2021
Q3 | $24.7M | Buy |
196,139
+4,368
| +2% | +$562K | 0.11% | 174 |
|
|
2021
Q2 | $26M | Buy |
191,771
+8,331
| +5% | +$1.1M | 0.11% | 173 |
|
|
2021
Q1 | $24.9M | Buy |
183,440
+21,754
| +13% | +$3.26M | 0.12% | 166 |
|
|
2020
Q4 | $22.8M | Buy |
161,686
+14,481
| +10% | +$1.85M | 0.11% | 165 |
|
|
2020
Q3 | $16.4M | Buy |
147,205
+15,606
| +12% | +$1.75M | 0.09% | 174 |
|
|
2020
Q2 | $14.7M | Buy |
131,599
+7,860
| +6% | +$774K | 0.09% | 177 |
|
|
2020
Q1 | $9.58M | Sell |
123,739
-9,650
| -7% | -$855K | 0.07% | 196 |
|
|
2019
Q4 | $12.7M | Sell |
133,389
-1,348
| -1% | -$117K | 0.07% | 210 |
|
|
2019
Q3 | $10.3M | Buy |
134,737
+6,011
| +5% | +$500K | 0.06% | 227 |
|
|
2019
Q2 | $11.3M | Buy |
128,726
+9,693
| +8% | +$827K | 0.07% | 204 |
|
|
2019
Q1 | $10.8M | Buy |
119,033
+23,570
| +25% | +$2.01M | 0.07% | 203 |
|
|
2018
Q4 | $6.85M | Sell |
95,463
-4,290
| -4% | -$346K | 0.05% | 239 |
|
|
2018
Q3 | $9.56M | Buy |
99,753
+37,420
| +60% | +$3.63M | 0.06% | 227 |
|
|
2018
Q2 | $5.93M | Buy |
62,333
+47,209
| +312% | +$4.34M | 0.04% | 265 |
|
|
2018
Q1 | $1.33M | Buy |
15,124
+13,957
| +1,196% | +$1.27M | 0.01% | 458 |
|
|
2017
Q4 | $99K | Sell |
1,167
-379
| -25% | -$31.8K | ﹤0.01% | 1053 |
|
|
2017
Q3 | $134K | Buy |
1,546
+821
| +113% | +$65.8K | ﹤0.01% | 983 |
|
|
2017
Q2 | $56K | Buy |
725
+298
| +70% | +$21.1K | ﹤0.01% | 1243 |
|
|
2017
Q1 | $30K | Sell |
427
-144
| -25% | -$9.67K | ﹤0.01% | 1462 |
|
|
2016
Q4 | $34K | Sell |
571
-210
| -27% | -$13K | ﹤0.01% | 1465 |
|
|
2016
Q3 | $52K | Buy |
781
+129
| +20% | +$7.98K | ﹤0.01% | 1313 |
|
|
2016
Q2 | $35K | Sell |
652
-366
| -36% | -$20.1K | ﹤0.01% | 1410 |
|
|
2016
Q1 | $53K | Sell |
1,018
-150
| -13% | -$7.79K | ﹤0.01% | 1310 |
|
|
2015
Q4 | $82K | Sell |
1,168
-155
| -12% | -$10.6K | ﹤0.01% | 1215 |
|
|
2015
Q3 | $82K | Buy |
1,323
+375
| +40% | +$29.6K | ﹤0.01% | 1229 |
|
|
2015
Q2 | $80K | Buy |
948
+498
| +111% | +$38.7K | ﹤0.01% | 1273 |
|
|
2015
Q1 | $34K | Hold |
450
| – | – | ﹤0.01% | 1557 |
|
|
2014
Q4 | $28K | Sell |
450
-150
| -25% | -$8.55K | ﹤0.01% | 1613 |
|
|
2014
Q3 | $31K | Hold |
600
| – | – | ﹤0.01% | 1592 |
|
|
2014
Q2 | $31K | Hold |
600
| – | – | ﹤0.01% | 1631 |
|
|
2014
Q1 | $28K | Hold |
600
| – | – | ﹤0.01% | 1656 |
|
|
2013
Q4 | $26K | Hold |
600
| – | – | ﹤0.01% | 1576 |
|
|
2013
Q3 | $26K | Hold |
600
| – | – | ﹤0.01% | 1580 |
|
|
2013
Q2 | $21K | Buy |
+600
| New | +$21.1K | ﹤0.01% | 1581 |
|
Other funds holding XBI
Fifth Third Bancorp's XBI Position: Q1 2026 in Review
Fifth Third Bancorp increased its State Street SPDR S&P Biotech ETF (XBI) stake by 19% in Q1 2026, buying an estimated $1.52M and bringing the position to 77,761 shares worth $9.93M. The position accounts for 0.02% of the portfolio, ranked #463.
Fifth Third Bancorp first reported a position in XBI in Q2 2013 and has held it in 52 quarters since. The position peaked at $26M in Q2 2021. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Fifth Third Bancorp held 77,761 shares of State Street SPDR S&P Biotech ETF worth $9.93M as of Q1 2026.
- Fifth Third Bancorp bought 12,160 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $1.52M.
- State Street SPDR S&P Biotech ETF made up 0.02% of Fifth Third Bancorp's portfolio in Q1 2026, its #463 holding.
- Fifth Third Bancorp first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 52 quarters since.
- Fifth Third Bancorp's State Street SPDR S&P Biotech ETF position peaked at $26M in Q2 2021.
- 814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.